Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
Clinical trial NCT06759064 · RECRUITING
Trial details
- NCT number
- NCT06759064
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-12
- Primary completion
- 2026-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.